ATE857T1 - Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. - Google Patents
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine.Info
- Publication number
- ATE857T1 ATE857T1 AT79104391T AT79104391T ATE857T1 AT E857 T1 ATE857 T1 AT E857T1 AT 79104391 T AT79104391 T AT 79104391T AT 79104391 T AT79104391 T AT 79104391T AT E857 T1 ATE857 T1 AT E857T1
- Authority
- AT
- Austria
- Prior art keywords
- membrane proteins
- neisseria meningitidis
- production
- vaccine containing
- optionally
- Prior art date
Links
- 108010052285 Membrane Proteins Proteins 0.000 title abstract 2
- 241000588650 Neisseria meningitidis Species 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 238000013019 agitation Methods 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782848965 DE2848965A1 (de) | 1978-11-11 | 1978-11-11 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine |
| EP79104391A EP0011243B1 (de) | 1978-11-11 | 1979-11-08 | Verfahren zur Herstellung von Membranproteinen aus Neisseria meningitidis und diese enthaltende Vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE857T1 true ATE857T1 (de) | 1982-04-15 |
Family
ID=6054405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT79104391T ATE857T1 (de) | 1978-11-11 | 1979-11-08 | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0011243B1 (show.php) |
| JP (1) | JPS5566519A (show.php) |
| AT (1) | ATE857T1 (show.php) |
| AU (1) | AU533386B2 (show.php) |
| CA (1) | CA1142083A (show.php) |
| DE (2) | DE2848965A1 (show.php) |
| DK (1) | DK154841C (show.php) |
| ES (1) | ES485715A1 (show.php) |
| IL (1) | IL58673A (show.php) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4317811A (en) | 1980-09-11 | 1982-03-02 | Merck & Co., Inc. | Herpes simplex type 1 subunit vaccine |
| JPH074267B2 (ja) * | 1982-12-02 | 1995-01-25 | ザ ロツクフエラ− ユニバ−シテイ | 免疫グロブリンａ結合性抗体 |
| US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| ATE346609T1 (de) | 1998-05-29 | 2006-12-15 | Novartis Vaccines & Diagnostic | Kombinierte meningitis b/c impfstoffe |
| DK2270173T3 (en) | 1999-05-19 | 2016-03-07 | Glaxosmithkline Biolog Sa | Neisserial combination compositions |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| GB9928196D0 (en) | 1999-11-29 | 2000-01-26 | Chiron Spa | Combinations of B, C and other antigens |
| DK1248647T3 (da) | 2000-01-17 | 2010-09-27 | Novartis Vaccines & Diagnostic | Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| WO2004014417A2 (en) | 2002-08-02 | 2004-02-19 | Glaxosmithkline Biologicals Sa | Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
| GB0316560D0 (en) | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| US7628995B2 (en) * | 2003-12-23 | 2009-12-08 | Glaxosmithkline Biologicals S.A. | Outer membrane vesicles and uses thereof |
| GB0419627D0 (en) | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| CA2654706A1 (en) | 2006-06-12 | 2007-12-21 | Nathalie Devos | Neisseria meningitidis lipooligosaccharide vaccine |
| DK2200642T3 (da) | 2007-10-19 | 2012-07-16 | Novartis Ag | Meningococvaccinepræparater |
| AU2009215364B2 (en) | 2008-02-21 | 2014-09-18 | Glaxosmithkline Biologicals S.A. | Meningococcal fHBP polypeptides |
| GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
| CA2747340A1 (en) | 2008-12-17 | 2010-06-24 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
| EP2440245B1 (en) | 2009-06-10 | 2017-12-06 | GlaxoSmithKline Biologicals SA | Benzonaphthyridine-containing vaccines |
| EP2470205A1 (en) | 2009-08-27 | 2012-07-04 | Novartis AG | Adjuvant comprising aluminium, oligonucleotide and polycation |
| US20110076300A1 (en) | 2009-08-27 | 2011-03-31 | Mariagrazia Pizza | Hybrid Polypeptides Including Meningococcal fHBP Sequences |
| TWI445708B (zh) | 2009-09-02 | 2014-07-21 | Irm Llc | 作為ｔｌｒ活性調節劑之化合物及組合物 |
| GB0917003D0 (en) | 2009-09-28 | 2009-11-11 | Novartis Vaccines Inst For Global Health Srl | Purification of bacterial vesicles |
| US20130022639A1 (en) | 2009-09-30 | 2013-01-24 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
| AU2010310985B2 (en) | 2009-10-27 | 2014-11-06 | Glaxosmithkline Biologicals S.A. | Modified meningococcal fHBP polypeptides |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| WO2011084549A1 (en) | 2009-12-15 | 2011-07-14 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
| BR112012022669A2 (pt) | 2010-03-10 | 2017-02-14 | Glaxosmithkline Biologicals Sa | composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina. |
| BR112012022896A2 (pt) | 2010-03-18 | 2018-03-27 | Novartis Ag | vacinas adjuvantes para meningococos do sorogrupo b |
| CA2792938C (en) | 2010-03-23 | 2018-07-31 | Irm Llc | Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| CA2810971C (en) | 2010-09-10 | 2020-11-03 | Novartis Ag | Developments in meningococcal outer membrane vesicles |
| EP2707009A1 (en) | 2011-05-12 | 2014-03-19 | Novartis AG | Antipyretics to enhance tolerability of vesicle-based vaccines |
| JP5957541B2 (ja) | 2012-02-02 | 2016-07-27 | ノバルティス アーゲー | 髄膜炎菌における増加したタンパク質発現のためのプロモータ |
| WO2013132040A2 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | In vitro potency assay for protein-based meningococcal vaccines |
| RU2644340C2 (ru) | 2012-06-14 | 2018-02-08 | Новартис Аг | Вакцины для менингококка серогруппы х |
| BR112015005056A2 (pt) | 2012-09-06 | 2017-11-21 | Novartis Ag | vacinas de combinação com sorogrupo b meningococcus e d/t/p |
| CN104602702B (zh) | 2012-09-18 | 2021-08-27 | 葛兰素史密丝克莱恩生物有限公司 | 外膜囊泡 |
| EA034954B1 (ru) | 2014-02-28 | 2020-04-10 | Глаксосмитклайн Байолоджикалс Са | МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp |
| WO2018042017A2 (en) | 2016-09-02 | 2018-03-08 | Glaxosmithkline Biologicals Sa | Vaccines for neisseria gonorrhoeae |
| JP7369690B2 (ja) | 2017-09-08 | 2023-10-26 | エヴェロ バイオサイエンシズ，インコーポレーテッド | 細菌の細胞外小胞 |
| EP3607967A1 (en) | 2018-08-09 | 2020-02-12 | GlaxoSmithKline Biologicals S.A. | Modified meningococcal fhbp polypeptides |
| EA202190914A1 (ru) | 2018-11-06 | 2021-08-03 | Глаксосмитклайн Байолоджикалс Са | Иммуногенные композиции |
| EP3799884A1 (en) | 2019-10-01 | 2021-04-07 | GlaxoSmithKline Biologicals S.A. | Immunogenic compositions |
| GB202115072D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
| GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
| GB202211033D0 (en) | 2022-07-28 | 2022-09-14 | Glaxosmithkline Biologicals Sa | Purification process |
-
1978
- 1978-11-11 DE DE19782848965 patent/DE2848965A1/de not_active Withdrawn
-
1979
- 1979-11-06 ES ES485715A patent/ES485715A1/es not_active Expired
- 1979-11-08 DE DE7979104391T patent/DE2962526D1/de not_active Expired
- 1979-11-08 EP EP79104391A patent/EP0011243B1/de not_active Expired
- 1979-11-08 AT AT79104391T patent/ATE857T1/de not_active IP Right Cessation
- 1979-11-09 IL IL58673A patent/IL58673A/xx unknown
- 1979-11-09 JP JP14456179A patent/JPS5566519A/ja active Granted
- 1979-11-09 AU AU52682/79A patent/AU533386B2/en not_active Ceased
- 1979-11-09 CA CA000339541A patent/CA1142083A/en not_active Expired
- 1979-11-09 DK DK475779A patent/DK154841C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0011243A1 (de) | 1980-05-28 |
| JPS5566519A (en) | 1980-05-20 |
| CA1142083A (en) | 1983-03-01 |
| AU533386B2 (en) | 1983-11-24 |
| IL58673A (en) | 1983-02-23 |
| DK475779A (da) | 1980-05-12 |
| DK154841B (da) | 1988-12-27 |
| DE2962526D1 (en) | 1982-05-27 |
| DK154841C (da) | 1989-06-05 |
| IL58673A0 (en) | 1980-02-29 |
| ES485715A1 (es) | 1980-05-16 |
| JPS6350332B2 (show.php) | 1988-10-07 |
| EP0011243B1 (de) | 1982-04-14 |
| DE2848965A1 (de) | 1980-05-22 |
| AU5268279A (en) | 1980-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE857T1 (de) | Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine. | |
| ATE195420T1 (de) | Methode zur herstellung von eicosapentansäuren | |
| DE69224124D1 (de) | Verfahren zur Herstellung von Dihomo-Gamma-Linolensäure und das in dieser enthaltende Lipid | |
| ATE59402T1 (de) | Verfahren zur abtrennung von cholesterin aus fettsubstanzen tierischen ursprungs und cholesterinarme fettsubstanzen. | |
| DE68906385D1 (de) | Verfahren und vorrichtung zur reinigung von wasser mittels polypyrrolidon. | |
| ATE69927T1 (de) | Verfahren zur herstellung eines molkeproduktes mit verringerter allergenitaet. | |
| ATE944T1 (de) | Verfahren zur herstellung von knochenersatzmaterial mit verbesserter biologischer stabilitaet auf der basis von kollagen und das erhaltene knochenersatzmaterial. | |
| ATE18845T1 (de) | Tierstreu sowie verfahren zu ihrer herstellung. | |
| DE3876477D1 (de) | Verfahren zur herstellung oder extraktion von aminosaeuren aus duenger. | |
| ATE123947T1 (de) | Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten. | |
| DE60107446D1 (de) | Gereinigtes cochinealpigment und verfahren zur herstellung desselben | |
| ATE42965T1 (de) | Verfahren zur herstellung von stabilen ozonisierten oelen aus ungesaettigten pflanzenoelen. | |
| ATE24475T1 (de) | Verfahren zur reinigung eines gemisches von wasser mit c1-c2-alkoholen das von der industriellen herstellung von ethanol stammt, mit hilfe eines extraktionsmittels. | |
| AT384032B (de) | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) | |
| ATE72756T1 (de) | Verfahren zur herstellung eines biologischen stoffes. | |
| ATE70452T1 (de) | Verfahren zur herstellung eines propolis|thanolextraktes. | |
| EP0607593A3 (de) | Verfahren zur Gewinnnung von Zellkulturen mit erhöhtem Gehalt an körpereigenen Zytokinen. | |
| ATE30161T1 (de) | Verfahren zur herstellung von globin aus haemoglobin und das in diesem verfahren erhaltene globin. | |
| ATE91304T1 (de) | Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe. | |
| ATE100148T1 (de) | Verfahren zur herstellung von hochgradig ungesaettigten fettsaeuren. | |
| FR2620726B1 (fr) | Procede de preparation d'un extrait de jasmin et extrait obtenu | |
| ATE116989T1 (de) | Verfahren zur reinigung von hemin, neues heminderivat und verfahren zur herstellung. | |
| ATE14596T1 (de) | Verfahren zur herstellung von ammoniumlactat enthaltenden mischungen und vorrichtung zur durchfuehrung des verfahrens. | |
| FR2429765A1 (fr) | Procede et agent d'adsorption pour isoler des enzymes et pour les preparer a l'etat pur | |
| ATE101393T1 (de) | Phenanthridinderivate, verfahren zu ihrer herstellung und mittel zur ausfuehrung des verfahrens. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| EELA | Cancelled due to lapse of time |